Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Psychedelics

Psychedelics

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • M&A
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

This Holding Company Wants To Buy Psychedelics-Focused Enterprise And Natural Products Brand

By Vuk Zdinjak
August 3, 9:29 AM
Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) has entered into a letter of intent with Melodial Global Health (formerly Creso Pharma) to acquire Sierra Sage Herbs, maker of the Green Goo, Southern B

PLSH

Read More
4 minute read
  • Cannabis
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More

By Lara Goldstein
August 3, 8:52 AM
A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances with that of classic drugs. 

ATAI

Read More
2 minute read
  • Cannabis
  • Global
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player

By Lara Goldstein
August 1, 5:46 PM
Optimi Completes Novel Extraction Process and Files U.S. Prov. Patent

MGCLF

Read More
2 minute read
  • Cannabis
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details

By Lara Goldstein
August 1, 3:43 PM
Clinical-stage psychedelics biotech Reunion Neuroscience (NASDAQ: REUN) and MPM BioImpact have completed their announced plan of arrangement for MPM&rsq

REUN

Read More
2 minute read
  • Cannabis
  • Contracts
  • Global
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics

By Lara Goldstein
August 1, 1:09 PM
As part of its business restructuring process and following its London clinics busin

AWKNF

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Psychedelics

Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill’s New Offer

By Lara Goldstein
August 1, 11:04 AM
Rose Hill, a Jamaica-based cultivator, supplier and exporter of premium psilocybin products and biomass to research partners and brands is now offering its first wellness retreat program under the name ONE Retreats. 

MYCOF

Read More
3 minute read
  • Cannabis
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

PharmAla Files IP Protection For Novel MDXX Molecule: Viability As Autism Spectrum Treatment

By Lara Goldstein
July 31, 6:05 PM
Canadian biotech company PharmAla Biotech Holdings (OTC: PMBHF) has filed a patent covering composition of matter of Novel Chemical Entity (NCE) PharmAla-1. 

PMBHF

Read More
2 minute read
  • Cannabis
  • Earnings
  • Guidance
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Increased Production & Retail Sales For Magic Truffles: Red Light Holland Balances 2023 Financial Results

By Lara Goldstein
July 31, 2:25 PM
Ontario-based all-mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) filed its audited annual financial statements, plus management takes and analysis, for the financial years ended March 31, 2023 and 2022. 2023's Numbers: 

TRUFF

Read More
3 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Top Stories

Woooo! Ric Flair-Inspired Vape Cartridges, Mini Bongs & More: Discover New Cannabis Products Hitting Stores

By Joana Scopel
July 29, 11:58 AM
Hey there, cannabis friends! Get ready for an exciting weekly roundup of the hottest cannabis product releases, brought to you by Benzinga.

SAM

Read More
3 minute read
  • Cannabis
  • Financing
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Small Pharma’s Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial

By Lara Goldstein
July 28, 4:28 PM
UK’s short-acting psychedelics developer Small Pharma (OTCQB: DMTTF) published its financial results for the fiscal first quarter ended May 31, 2023:

ATAI

Posts pagination

Previous 1 … 17 18 19 … 68 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service